The pharmacokinetics of polymer-bound adriamycin

This publication has 22 references indexed in Scilit:

• Reduction in doxorubicin toxicity following liposomal delivery
  Cancer Treatment Reviews, 1987
• Effect of molecular weight (M_w) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats
  Journal of Biomedical Materials Research, 1987
• Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?
  Cancer Drug Delivery, 1987
• Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing Ridgway Osteogenic Sarcoma (ROS)
  European Journal of Cancer and Clinical Oncology, 1986
• Preparation and evaluation in vitro and in vivo of fibrinogen microspheres containing adriamycin.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part I
  Journal of Controlled Release, 1985
• Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers
  Biomaterials, 1985
• Adriamycin‐loaded albumin microspheres: Preparation, in vivo distribution and release in the rat
  Biopharmaceutics & Drug Disposition, 1985
• Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles
  Journal of Pharmaceutical Sciences, 1982
• Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomes
  European Journal of Cancer and Clinical Oncology, 1982